Makalah Kasus 4 Hiv

7/26/2019 Makalah Kasus 4 Hiv

1/39

KELOMPOK X

WANITA HAMIL DENGAN RIWAYAT DRUG USER

Modul Organ Sist! R"rodu#si

03009030 ARUMTYAS CAHYANING W

03009040 AYUNDA AFDAL

03009060 DELITA SAFIRA DANA

03009070 DIANITA KUSUMA WIJAYA

03009080 EVA MARIS SAHARA

03009090 FIRDHA AQMARINA

03009100 GADISTA P ANNISA

03009110 HEN!A AYU PRIMALITA

03009111 HERJUN" DARPIT"

030091#1 INDRASTITI PRAMITASARI

03009130 KHRISNA PARAMAARTHA

03009131 KIKI HAERA RI!KY

03009138 M EVAN EWALD"

03009140 MADE AYU INTAN WINAYATI "

F$%&'($) K*+,%(*-$. U./*-)/($) T-/)$%(/

J$%$-($ #6 J$.&$-/ #01#

1


2/39

$A$ I

PENDAHULUAN

P*.$'$2&.$$. .$-%,$5 $+$'$2 *.&.$$. $( $($& ,$( *+/) (*-(*.(& $.

+/&.$%$. )*$-$.$. $($& ($.$ -*)* +,%(*- P*.&.$$. $( /./&. *-$$:$$5 +$-/

**-/$. ,-$'5 /.2$'$)/ )$$/ **-/$. /.(-$*.$ ;*$%$/$. /%)**-(/ +*$5

$'$/)*5 $'/$5 )$%/( %*$'$5 +$. )%/. -$)25 +$. *-'$.)&. )*%/($- 1 /.&5 )*(*'$2 /(&

$)&% %* >$)* '$(*. $($& %-,./) +/$.$ $)/*. ($$% )**-(/ ,-$. )*2$( +$'$ *%)/ $/% $(2,*. $&&. ,,-(&./)(/% $%$.

*.*-$. $)/*. )*2/.$ -,.,)/) $%$. )$.$( &-&% &.(&% $)/*. HIV )*.+/-/ &%$.'$2

*.*$ %*$(/$. $/ *.+*-/($.$5 .$&. *.$%/( *.*-($.$'$2 $. *-&$%$.

*.*$ %*$(/$. $)/*. +$-/ *.$%/( -/.$.)**-(/ /.>'&*.$ )$$/ (&*-&',)/) +$.

S$-,$ K$,)/

P*.&'$-$. HIV +$-/ )$(& $)/*. %* $)/*. '$/..$ &. *-$-/$)/5 +$-/ *.&'$-$. )*$-$

)*%)&$' ;)*%-*( $/.$ +$. )**.=5 .,. )*%)&$' ;*.&.$$. &)/

+$-$2= )$$/ %,.*./($'; $%(,- -/)/%, &.(&% (*-(&'$- HIV

2


3/39

$A$ II

LAPORAN KASUS

Ssi %

N Y #7 ($2&.5 +$($. %* ,'/%'/./% %*/+$.$. +$. %$.+&.$. &.(&% **-/%)$

%*2$/'$. M*-&$%$. %*2$/'$. *-($$ ;G1= HPHT 7 ,-$)/ (*.($. 2$' /./5 %$-*.$ ($2&. $. '$'& $)/*.

+$. )&$/ */'/%/ -/?$$( +-& &)*- /)/% +/+$$(%$. B

K*$+$$. && B@$/%

S&2& B 3657C

TD B11070 H

RR B #4*./(

N$+/ B 90 *./( -*&'$- /)/ &%&

M$($ B K,.


4/39

HIV -$/+ (*)( B;=

P$+$ **-/%)$$. )*'$.


5/39

$A$ III

PEM$AHASAN

@*-+$)$-%$. %$)&)5 +/+$$(%$. /.>,-$)/ *.*.$/ $)/*.5 )*$$/ *-/%&(B

'(% Idntitas "asin

N$$ '*.%$ B N Y J*./) K*'$/. BW$./($

U)/$ B #7 ($2&. S&%& $.)$ B :

P*%*-$)$. $+$'$2 *.$%/( T@C=

5


6/39

A$%$2 $+$ )'*-$ $)/*. *-.$2 *-?$-.$ %&./. ;C&-/$ 2*$(/(/) $($& *.$%/( 2$(/=

A$%$2 $)/*. *.$'$/ *.&-&.$. *-$( $+$. ;C&-/$ HIV=

A$%$2 $)/*. &+$2 *.$'$/ *.&-&.$. %*)*2$($. ;C&-/$ HIV %$-*.$ $+$

*.$%/( HIV +$$ ($2$. (&&2 *.&-&. +$. $)/*. $%$. &+$2 (*-)*-$. *.$%/(=

A$%$2 )*'$'& '*'$2

A$%$2 ?$-.$ $/- )*./ ,%'$( /-/ $/- (*2

A$%$2 )&+$2 *-.$2 *'$%&%$. )-**./. T"RCH5 HIV5 H*$(/(/)

.( R/?$$( P*.$%/( D$2&'&

A$%$2 $)/*. *-.$2 *.+*-/($ *.$%/( *-$(5 )**-(/ -/?$$( 2/*-(*.)/5 -/?$$(

*.$%/( /.


7/39

0( Ri,a-at #+iasaan P$)/*. +$. )&$/ */'/%/ -/?$$( +-& &)*-


8/39

'('(% Kadaan U!u! B @$/%

'('(& Tanda 2ital

$ S&2& B 3657,C

N,-$'.$ 365:375#0C P$+$ $)/*. /./ )&2&.$ .,-$' S*+$.%$. $+$ *.+*-/($

HIV /$)$ +/(*&%$. )&2& $. >*-/) $+$ >$)* $%&( ;3:6 /.& )*(*'$2

(*-/.>*%)/=1N$&. )*(*'$2 /(&5 $$/'$ /.>*%)/ HIV *$)&%/ >$)* $)/(,$(/% ;8:

10 ($2&.=5 $%$ ($.+$:($.+$ /.>*%)/ $%&( (*-)*&( +$$( *.2/'$.

D*.&( .$+/ B 90 *./(

N,-$'.$ 60:100 %$'/*./(

P$+$ $)/*. /./ +/+$$(%$. +*.&( .$+/ .,-$'5 2$' /./ *./.+/%$)/%$. $2?$ (/+$%

(*-*%(/>

T*%$.$. +$-$2 B 11070 H

N,-$'.$5 )/)(,'/% 1#0 +$. +/$)(,'/ 80

+ P*-.$$)$. B #4 *./( N,-$'.$ 16:#0*./( N$&. $+$ %$)&) /./5 *./.%$($. *-.$$)$. $.

(*-


9/39

/$)$ +/+$$(%$. *.&-&.$. *-$( $+$. ,)/) 1

III( K"ala dan L)r B

$ M$($ B K,.


10/39

3II(Pa-udara B :

IX( Gnitalia E#strna dan IntrnaB :

XI( Anus dan r.tu! B :

XII( E4tr!itas atas dan +a,a) B A%-$' 2$.$(5 ,*+* ;:=

A%-$' 2$.$( *./.+/%$)/%$. $2?$ *->&)/ +$-$2 %*


11/39

>&.)/ SSP A%(//($) *-$%$. 11


12/39

V$-/$)/ DJJ +/)*$%$. %*)*/$.$. -$.)$. SSP5 +$$( *-&$2 +*.$. $+$.$

*-$%$. $%(,- /.(-/.)/%= $($& %,.(-$%)/ &(*-&) ;>$%(,- *%)(-/.)/%= P$+$

2/,%)/$5 DJJ $%$. *./.%$( )*$$/ &$$ %,*.)$)/5 (*($/ $+$ %*$+$$.

$.,%)/$ >-*%&*.)/ DJJ *-%&-$. $($& *.2/'$. )*%$'/&. +/*-/ -$.)$.

S*'$/. /(&


13/39

7nis

P!ri#saan

Hasil -ang

dida"at

Kadar nor!al Intr"rtasi )asil

D$-$2 R&(/.B

H*,',/. 1# +' 11:165 +' N,-$'

Lu#osit 4 000 L >(999:

%9(999


14/39

(*-/' )**. *.&.*%)/ +$'$ (&&25 */(& ,)/( /$)$.$

*%)/ HIV P*./.%$($. LED *.&.*%)/ %-,./)

J$+/5 $+$ **-/%)$$. +$-$2 -&(/. /./ +/+$$(%$. $2?$ $)/*. *.$'$/ /.>*%)/

%-,./)5 +$'$ 2$' /./ *.*$.$ $+$'$2 HIV

P$+$ **-/%)$$. '$.*%)/ H*$(/(/) @ U-/.$'/)$ ;:=5 $. *-$-(/ .,-$' $+$ **-/%)$$. L$'& $+$

**-/%)$$. HIV -$/+ (*)( +/+$$(%$. 2$)/' $. ,)/(/>5 /./ *.$.+$%$. $2?$ $)/*.

,)/(/> (*-/.>*%)/ HIV L$'& /-$' ',$+ $. *.$$/ 10000 ,/*)5 /./ *.$.+$%$.

$2?$ -*'/%$)/ /-&) $+$ DNA )*' 2,)( -*'$(/> (/./ HIV /-$' ',$+ (*)( $+$'$2

*.&%&-$. )*$-$ %&$.(/($(/> *.*.$/ RNA +$-/ HIV HIV /-$' ',$+ /./ *.(/. &.(&%

*,./(,- )($(&) *.$%/( HIV5 *-*.$.$$. (*-$/ +$. *-%/-$$. -,.,)/) S**.($-$

CD4 $+$ %$)&) /./ )&+$2 +/$?$2 $.%$ .,-$'5 .$&. *'& $)&% $+$ >$)* -*.($.

)*2/.$ &.%/. $)/*. *'& (*-%*.$ /.>*%)/ ,,-(&./)(/% J&'$2 CD4 $. +/$?$2

$($& )$$ +*.$. #005 $%$ $)/*. (*-)*&( )&+$2 (*-%*.$ AIDS N/'$/ CD4 /./ /5 &.(&% *.*($2&/ +*.&(


15/39

'(> Da0tar Masala)

@*-+$)$-%$. 2$)/' $.$.*)/)5 **-/%)$$. >/)/% +$. *.&.($-

$)$'$2 N Y )*$$/ *-/%&(B

Da0tar Masala) Dasar Masala) Hi"otsis

R/?$$( IVDU A.$.*)/)B

- P$)/*. +/$.


16/39

$+$ %*2$/'$..$- P$)/*. +$. )&$/ ($2&.

$. '$'& $)/*. */'/%/

-/?$$( +-& &)*- *%(/>

+= S* (-$./((*+ +/)*$)*

T$%/.,* P**-/%)$$. F/)/%B

RR #4*./(

H/,(*)/)B

$= K*2$/'$.

= P*.$%/( $-&

L*&%,*./$ P**-/%)$$. '$,-$(,-/&B

- L*&%,)/( 4000'

H/,(*)/)B

$= I.>*%)/ /-&)= K*'$/.$. )&:)& (&'$.

= HIVAIDS

L/>,*./$ P**-/%)$$. '$,-$(,-/&B

- H/(&. *%)/ /-&) HIV A.$.*)/)B

- L/$ ($2&. $. '$'&

$)/*. +$. )&$/ */'/%/

-/?$$( +-& &)*-


17/39


18/39

C$-$ $)&%.$ /-&) HIV %* +$'$ )*' (-,/) $/(& CD4 +$. $%-,>$B PAT"GENESIS

B

18

Gp120nuc!eus

P24Re"erse

#ranscriptas

Protein

en"e!ope

G1#0 *-/%$($.

+*.$. -**(,-

)*)/>/% +/ CD4

D/($$2 /%$($. ,-*)*(,-

,'*2 2*,%/.* CCR +$.

CCR4

P*.*(-$)/ )*' /-&) %*

+$'$ )*' 2,)( ;=

T*-&)/ /-&) $.

$)&% %* +$'$ )*'

2,)( +*.$. 41

S*' /-&) &.,$(*+ +$'$

)/(,'$)$

RNA /-&) +/&$2

*.&)/

%*+$'$ .&%'*&) )*' 2,)(

I.(*-$)/ DNA )*' /-&) +$.

)*' 2,)(

M**.(&% RNA

/-&) $. $-&

S/.(*)/) -,(*/. /-&)

+*.$. *.,/ RNA

/-&) $-&

T*-*.(&% $)/+2$)/'%$. VIRI"N $. $-&

*.&


19/39

J$'&- T-$.)/)/ HIV

T*-/.>*%)/ +$-/ $)$.$. )*%)&$'

M,(2*- (, 2/'+ (-$.)/))/,.

I.*%)/ HIV +$-/

/& %* $/5 +$$( +/'$%&%$. 2$' )*$$/ *-/%&(B

1=Medikamentosa

P**-/$. (*-$/ ARV ;$.(/ -*(-,/-&)= )*$-$ %,/.$)/5 %,/.$)/ (*-)*&(

+//.+/%$)/%$. $+$ $)/*. /./ %$-*.$ /-$' ',$+.$ )&+$2 '*/2 +$-/ 1000 ,/*)' ARV

/./ +/&'$/ )*)**-$ &.%/. %$-*.$ )*$%/. (/./ %$+$- HIV $%$ $%$. )*$%/. *)$-

-*)/%, *.&'$-$. $+$ $/ )$$( +/%$.+&.$.5 )*-($ %$+$- HIV $. (/./ +$$( )*$%/.

*.&-&.%$. /&./($) /& )*2/.$ *./.%$(%$. -*)/%, (/&'.$ /.>*%)/ ,,-(&./)(/%

)**-(/ (&*-%&',)/)5 (,%),'$),)/)5 2*-*) +$. %$.+/+/$)/)

R*/*. ARV *'/&(/ $.$', .&%'*,)/+$ ;/+,&+/.5 $')/($/.5 +/+$.,)/.5

)($&+/.5 '$/&+/. +$. $$%$/-=5 $.$', .,.:.&%'*,)/+$ ;.*/-$/.5 +*'$/-+/.5

*>$/-*.=5 +$. /.2//(,- -,(*$)* ;/.+/.$/-5 -/(,.$/-5 )$%&/.$/-5 .*'>/.$/-5 $-*.$/-=

P$+$ ?$./($ 2$/' (*-$/ ARV (*-)*&( +/*-/%$. )*$ (/./.$ $.%$ ,-($'/($) +$.

19

L*&%,)/( '/>,)/(

LED 5 HIV -$/+(*)( ;=

M*./.$'%$. )*'2,)( )*' 2,)( *.


20/39

,-/+/($) Y$. *-'& +/*-2$(/%$. $+$'$2 *.2/.+$-/ *>$/-*. $+$ %*2$/'$.

(-/*)(*- *-($$ )*-($ /'$ /& 2$/' (*-)*&( *.+*-/($ (&*-%&',)$ )*$/%.$ (/+$%

+/*-/%$. .*/-$/. P**-/$. (*-$/ ARV /./ *-'& +/,./(,- +*.$. **-/%)$ CD4

+$. /-$' ',$+ H$)/'.$ +/2$-$%$. (*-&) %,.(/.& 1%


21/39

: M*.*% )$/. ,$( ARV +/*+&%$)/ $2?$

(/./.$ ,-/+/($) +$. ,-($'/($) $/ +/-/.$ +$. $/ '*/2 *)$- /'$ (/+$% +/(*-$/

ARV

I.(-$$-(&

P-,)*) %*'$2/-$. )*$/%.$ *'$'&/ )*%)/, )*)$-*$ (*-*.$.$5 2$' /./ &.(&% *.*$2

*.&'$-$. HIV $+$ $/ S*$ >$%(,- $-$ *.&'$-$. )$$( *-)$'/.$. $/(& *'$'&/

*.$&-$. +$-$2 /& +$. $/5 *-)$'/.$. $. '$$ +$. %*(&$. *$2 '*/2 +$-/ 4


22/39

ASI +/*-/%$. *%)%'&)/>5 %$-*.$ /'$ +/($$2 PASI5 PASI (*-)*&( $%$. *.*$%$.

*-+$-$2$. %*/' $+$ &)&) $/ +$. /-&) +$'$ ASI $%$. '*/2 &+$2 +/)*-$

ASI *-$2 +/$)(*&-/)$)/ $($& ?$+$2 ASI +/$)&%%$. %*+$'$ $/- $. $-& )$>,-+$'* ;(*-*$)/'* ;-$%(/)=5 $*($'* ;+/(*-/$ ,'*2

'/.%&.$.=5 )$>* ;$$.=5 +$. )&)($/.$'* ;*-%*)/.$&.$.=

: E+&%$)/ $$- PASI +/*-/%$. +$'$ *%)/ )*2/$ )*-/.%$'/ $/ $. +/*-/ PASI '*/2

*-*)/%, (*-%*.$ /.>*%)/=

: P*-'&.$ )/%,),)/$' )&,-(5 (*-&($$ )$$( *.&.& +/$.,)/) /.>*%)/ *+/$(-/% $+$

$/.$ S*2/.$ *-'& &'$ **-/ *+&%$)/ $+$ %*'&$-$ (*-+*%$( $)/*. &.(&%

**-/%$. )&,-( )/%,),)/$' (*-)*&(

: K,.)*'/. */'/2$. $'$( %,.(-$)*)/

@/'$ $)/*. +$. *%)/ HIV )*$/%.$ */'/2 %,.(-$)*)/ $-/*- %,.+,

P*-'& +/*+&%$)/%$. $2?$ %*&.%/.$. $%$. (/&' *>*% (*-2$+$ %$+$- 2,-,. /'$ $)/*.

*/'/2 %,.(-$)*)/ ,-$' $($& )&.(/%$. S*+$.%$. AKDR ;$'$( %,.(-$)*)/ +$'$ -$2/=

)**-(/ IUD +$$( +//'/2


23/39

: A!T +/(*-&)%$. )*'$$ 7 2$-/

I.(-$$-(&/'$ /& *'& *-.$2 +/(*-$/ )*'$$ %*2$/'$.

R*/*.B : NVP +,)/) (&.$' A!T &.(&% $/ $+$ 48


24/39

$+$ $/.$

+ M*././(/) K-/(,%,%$'

M*././(/) $+$'$2 /.>'$$)/ $+$ *-$.* +$. $/-$. )*%/($- ,($% +$.

)/.$' ,-+ ;*./.*)= P*.$%/( /./ *-&$%$. *.$%/( ))(* )$-$> &)$( $.

$.$% *-%$/($. +*.$. /.>*%)/ HIV P*.$%/( /./ +/)*$%$.,'*2 *%)/ *$(/%$. /./ +/)*$%$. ,'*2 $-$)/( Toxoplasma gondii P$-$)/( /./

+/)*$-%$. ,'*2 %&/. K&/. $. (*-/.>*%)/ $%$. **$-%$. $-$)/(.$ *'$'&/

%,(,-$. *-*%$5 %*&+/$. $-$)/( $%$.*.*$- %* 2*?$.'$/..$

S*'$/. -*.($. (*-*%)/ ,,-(&./)(/%5 HIVAIDS


25/39

Ad 3ita!* Du+ia ad $ona!

K$/ *.*.(&%$. -,.,)/) $+ /($ +&/$ $+ ,.$ %$-*.$ $$/'$ N Y

*.,.)&)/ ,$( $.(/-*(-,/-$' )*$-$ (*-$(&-5 N Y (/+$% $%$. (*-%*.$ *.$%/(

,,-(&./)(/% +$-/ HIV +$. HIV (/+$% $%$. *.&'$-/


26/39

$A$ I3

TIN7AUAN PUSTAKA

=(% $arir Plasnta

P'$)*.($ *-$)$' +$-/ (-,>/'$) P'$)*.($ */'/%/ **-$$ >&.)/ $/(& &.(&%

-*)/-$)/5 *.$'&-%$. .&(-/)/ +$-/ /& %* &.)/ &.(&% )*$$/ *-$. &.(&% *.*'*%)/ $(:$( +$-/

/& $. +$$( )$$/ %* ,'$)

3 M*-$.$ $)$'/) )/(,(-,>

4 M*-$.$ $)$'/) *.+,(*' %$/'*-

S/(,'$)$ *.+,(*' %$/'*-

26


27/39

=(& In0#si -ang da"at ditular#an !lalui 5aru! sunti# "ada I3DU

%( HI3//*. V/-&)5 $+$'$2 /-&) $. *.*-$. )/)(*

%*%*$'$. (&&2 $.&)/$ +$. %*&+/$. *./&'%$. AIDS HIV *.*-$. )$'$2 )$(&

$/$' ?$ %*&.%/.$. $+$ 3 $/ $. '$2/- +*.$.

HIV ,)/(/>

27


28/39

+ S*$-$ '$.)&. ;(-$.)>&)/ +$-$25 -,+&% +$-$2 $($& (-$.)'$.($)/ ,-$. (&&2 $.

(*-*$- HIV= ' L*?$( $'$(:$'$( ;$)/'/($) && *-)$$5 )**-(/ (*'*,. &&5 WC &&5 +$.

%,'$ -*.$.

C/&$.5 )*.,'$.5 *'&%$. +$. %*/$($. )*2$-/:2$-/ '$/..$ L*?$(

%*-/.$(5 $($& //($. .$&%

&( H"atitis $

H*$(/(/) @ $+$'$2 )&$(& *.$%/( 2$(/ $. +/)*$%$. ,'*2 /-&) 2*$(/(/) @5 )&$(&

$.,($ >$/'/ 2*$+.$/-&) $. +$$( *.*$%$. *-$+$.$. 2$(/ $%&( $($& *.$2&.

$. +$$( *-'$.*%)/ H@V +$-/ /& 2$/' %*$+$ $/ $. +/'$2/-%$..$ +$$(

(*-


29/39

C$-$ *.&'$-$. 2,-/,.($' (*- *'$'&/ ,-*)$. $($& $-$)/ %&'/( +$. -$+$. %&'/(

b. Mlalui Sla"ut Lndir

S*'$&( '*.+/- $. +/+&$ *.


30/39

P*.&'$-$. H*$(/(/) C /$)$.$ *'$'&/ %,.($% '$.)&. +*.$. +$-$2 $($&

-,+&%.$ +$. *%)/

H*$(/(/) C *'$'&/ 2&&.$. )*%)&$' '*/2 (/./ $+$ ,-$. $. *&.$/ '*/2 +$-/

)$(& $)$.$.

P*.&'$-$. H*$(/(/) C *%)/ $+$ endokardium ;)*'$&( +$$( (*-*%)/ $+$'$2 %$(& $. $.,-$' $($& %$(&

$. -&)$% (*($/ %$(& $. .,-$'&. +$$( (*-/.>*%)/ ,'*2 $%(*-/ $. $-*)/>5 (*-&($$

*%)/ %*/' $+$ %&'/( +$. /.>*%)/ $+$ $/$. (&&2 '$/..$5

/)$ *-(/.+$% )*$$/


31/39


32/39

=('(& Pnularan HI3*%)/

HIV +$$(


33/39

S**-(/ +/(&.$%(,- -/)/%, *.&.$%(,- &($$ &.(&% *.


34/39

F$%(,- $. $'/. &($$ **.$-&2/ -/)/%, *.&'$-$. HIV +$-/ /& %* $/

$+$'$2 %$+$- HIV ;viral load= +/ +$-$2 /& $+$ *.


35/39

: K*(&$. *$2 '*/2 +$-/ 4 *%)/ /-&)5

$%(*-/5 $-$)/(

I& *.$'$/ *$2

%*(&$. '*/2 +$-/ 4 *%)/ '$/..$=

@$/ */'/%/ '&%$ +/

&'&(

=('(' Klasi0i#asi In0#si HI3


36/39


37/39

$A$ 3

KESIMPULAN

HIVAIDS *-&$%$. )$'$2 )$(& *.$%/( $. +$$( +/(&'$-%$. *'$'&/ $/'/ -*(-,/-/+$* +$. *.&) '*.(//-&) HIV +/$/ *.*%)/ HIV $. '*/2 )*-/. (*-


38/39

K*&.%/.$. N Y *./+$ *.$%/( /./ +/$%/$(%$. N Y +$. )&$/.$ $+$'$2 $.($.

*.&.$ .$-%,$ ,- HIV A$/'$'* $( B 2((B????*+,2/:$/+)*+/$':

2/)(,-:$.+:2)/$':*$:>,-:2/:/.>*(/,. U+$(* ,. B A-/' 8 5 #010 A*))*+ ,. B

J$.&$- #4 5 #01#

# M,)* JC5 A'$)$2 M5 H&+,., ST5 H$.+$$5 H$+/)$&(-$ W P**-/%)$$. G/.*%,',/%

I. B I'& K$.+&.$. A.?$- M5 @$/$+ A5 P-$,?, RP ;*+/(,-= 3-+E+ J$%$-($B PT @/.$

P&)($%$ S$-?,., P-$?/-,2$-+


39/39

4 A$+/ A K$-+/,(,%,-$>/ J$./. +$. V*',)/*(-/ D,'*- I.B S$/>&++/. A@5 R$2/2$+2/ T5

W/%./ D$'$ ")(*(-/ I.B S$/>&++/. A@5 R$2/2$+2/ T5 W/%.

Documents

Makalah Kasus 4 Hiv